| Product NDC: | 0115-8344 | 
| Proprietary Name: | ALPRAZOLAM | 
| Non Proprietary Name: | ALPRAZOLAM | 
| Active Ingredient(s): | 3 mg/1 & nbsp; ALPRAZOLAM | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, EXTENDED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0115-8344 | 
| Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077968 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20070524 | 
| Package NDC: | 0115-8344-13 | 
| Package Description: | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-8344-13) | 
| NDC Code | 0115-8344-13 | 
| Proprietary Name | ALPRAZOLAM | 
| Package Description | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-8344-13) | 
| Product NDC | 0115-8344 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | ALPRAZOLAM | 
| Dosage Form Name | TABLET, EXTENDED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20070524 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. | 
| Substance Name | ALPRAZOLAM | 
| Strength Number | 3 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |